Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer [NA]
This document is an update on a neoadjuvant dietary intervention trial for intermediate-risk prostate cancer, currently active but not recru…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Exercise-induced Steroid Changes in Active Surveillance for Prostate Cancer [NA]
A clinical trial studying exercise-induced changes in steroid levels in men with prostate cancer under active surveillance; recruitment has …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy [Phase 3]
Clinical trial update for a Phase 3 study evaluating 64Cu-SAR-bisPSMA PET imaging in high-risk prostate cancer prior to radical prostatectom…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study [Phase 2]
A Phase 2 clinical trial update evaluating the addition of Relugolix to standard radiation therapy for advanced, oligometastatic prostate ca…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) [Phase 3]
A Phase 3 trial comparing Opevesostat (MK-5684) to an alternative novel hormonal agent in metastatic prostate cancer is currently recruiting…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer [Phase 3]
Phase 3 trial evaluating Copper-64 PSMA I&T PET imaging for men with newly diagnosed prostate cancer. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial [Phase 3]
Two Phase 3 studies in unfavorable intermediate-risk prostate cancer are evaluating tailored treatment intensity based on a gene risk score.…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery [NA]
A Memorial Sloan Kettering Cancer Center trial is recruiting to study adherence to sexual rehabilitation after prostate cancer surgery, focu…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer [Phase 2, Phase 3]
VA-sponsored seamless Phase II/III randomized trial evaluating standard systemic therapy with or without PET-directed local therapy for olig…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-Risk Prostate Cancer: A Multicenter Prospective, Single-Arm Clinical Study [EARLY_Phase 1]
A multicenter Phase 1 study assessing safety and efficacy of combining docetaxel, darolutamide, and homoharringtonine with androgen deprivat…
-
CLINICAL_TRIALS withdrawal · 2026-04-08Clinical Trial Update: Niraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations [Phase 2]
A Phase 2 trial evaluating the combination of niraparib, abiraterone acetate, and prednisone for metastatic hormone-sensitive prostate cance…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study [NA]
A completed clinical trial evaluating survivorship care plans and telehealth education (the IMPACT Study) aimed at improving access to cance…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy [NA]
A clinical trial evaluating whether creatine supplementation combined with resistance training improves sarcopenia-related parameters in pat…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Cleveland African American Prostate Cancer Project [NA]
Clinical trial update for the Cleveland African American Prostate Cancer Project indicates the study is currently recruiting participants, s…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy [NA]
Clinical trial NCT07516808 investigates intraoperative margin assessment during prostatectomy for prostate cancer using non-linear microscop…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Moderately Hypofractionated Radiotherapy for Prostate Cancer. [NA]
An update on a clinical trial evaluating moderately hypofractionated radiotherapy for prostate cancer. The sponsor is Tatarstan Cancer Cente…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Ablative Radiotherapy to Consolidate Maximal Systemic Response in Metastatic Prostate Cancer (ANCHOR-Prostate) [Phase 2]
An ongoing Phase 2 clinical trial evaluating ablative radiotherapy to consolidate maximal systemic response in metastatic prostate cancer is…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer [Phase 1]
This ClinicalTrials.gov update describes a Phase 1 study of combining Lutetium-177-PSMA-617 with Carboplatin in metastatic castration-resist…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors [Phase 1]
This clinical trial update reports a Phase 1 dose-determining study of EXS74539 (REC-4539) in participants with select solid tumors, current…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX
A multi-center, prospective observational study of patients treated with ORGOVYX (relugolix) for prostate cancer; the study is currently act…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy
A clinical trial update indicates the study on the prognostic value of early postoperative PSA for oncological outcomes after radical prosta…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer [Phase 1, Phase 2]
This clinical trial update describes AZD0516 as a monotherapy and in combination for metastatic prostate cancer, conducted in Phase 1 and Ph…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy Using SBRT for Prostate Cancer to Reduce Treatment Toxicity [Phase 2]
A Phase 2 trial investigating molecular imaging-guided radiation dose escalation to recurrent sites and de-escalation to uninvolved areas du…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial [Phase 3]
A Phase 3 trial (ASPIRE) is testing whether adding docetaxel to hormonal therapy and apalutamide improves outcomes in men with metastatic ca…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors [Phase 1]
Phase I study of SYS6043 in patients with advanced or metastatic solid tumors is currently recruiting, including prostate cancer, small cell…